PepGen Inc.
NASDAQ:PEPGBiotechnology
+$0.09 today
- Market cap
- $265.27M
- Beta
- 1.93
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$1.12
Volume 3.39M
Average 1.37M
Returns on capital
PepGen Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-60.8%
avg -46.0%
ROIC
-56.9%
avg -43.1%
ROA
-51.6%
avg -38.1%
Analysis
ROA is currently the strongest return metric at -51.6% versus its period average of -38.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
James G. McArthur | President, Chief Executive Officer, Treasurer, Secretary & Director | USD 1.06M | 64 | 296.33K | 0.43% |
Noel Donnelly | Chief Financial Officer | USD 742.6K | 56 | 111.60K | 0.16% |
Joseph D. Vittiglio | Chief Business & Legal Officer and Secretary | USD 391.64K | 54 | — | — |
Paul D. Streck | Executive Vice President and Head of Research & Development | USD 332.73K | 62 | — | — |
Michael Zhao | Vice President & Head of Biometrics | — | — | — | — |
Hayley Parker | Senior Vice President of Global Regulatory Affairs & Quality | — | — | — | — |
Kasra Kasraian | Chief Technology Officer | — | 59 | 50.07K | 0.07% |
Emiko Bryant | Senior Vice President of HR & Administration | — | — | — | — |
Melissa Michaels | Executive Director & Head of Regulatory Affairs CMC | — | — | — | — |
Pallavi Lonkar | Vice President & Head of Preclinical | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding May 21, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
7
$59,312.24
Net Transaction Value
−$59,312.24
Net selling
Most Active
STRECK PAUL
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| May 21, 26May 21, 2026 | Kasraian Kasra Direct | Sell | $1.7K$1,739.39 |
| Mar 4, 26Mar 4, 2026 | STRECK PAUL Direct | Sell | $11.4K$11,413.36 |
| Mar 4, 26Mar 4, 2026 | STRECK PAUL Direct | Sell | $295.5$295.54 |
| Mar 4, 26Mar 4, 2026 | Donnelly Noel Direct | Sell | $12.7K$12,659.36 |
| Mar 4, 26Mar 4, 2026 | Donnelly Noel Direct | Sell | $328.9$328.90 |
| Mar 4, 26Mar 4, 2026 | McArthur James G Direct | Sell | $32K$32,047.12 |
| Mar 4, 26Mar 4, 2026 | McArthur James G Direct | Sell | $828.6$828.58 |
Summary
Insiders reported 0 buys worth $0.00 and 7 sells worth $59,312.24 over the last 12 months. That adds up to net selling of $59,312.24. STRECK PAUL was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does PepGen Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about PEPG's management, answered from reported figures.
Who manages PEPG?
PepGen Inc. (PEPG) lists 10 active executives. The top listed executive is Paul D. Streck, Executive Vice President and Head of Research & Development.
Are PEPG insiders buying or selling?
Recent insider activity shows net buying of $140.43M.
Continue the stock analysis
Jump to another research area for this company.